Prostate Cancer Treatment Helped by Novel Technology

by Savitha C Muppala on  May 15, 2010 at 4:36 PM Cancer News   - G J E 4
Prostate Cancer Treatment Helped by Novel Technology
Queen's University scientists have developed a new method of performing lab tests which could aid prostate cancer treatment.

It will allow them to identify with unprecedented accuracy losses of a gene called PTEN that is associated with an aggressive group of prostate cancers.

The improved Fluorescence In-Situ Hybridization (FISH) platform uses DNA probes to analyze the three-dimensional space cancer cells occupy in routine clinical microscopic analysis of tissue sections of tumors. It will provide a more accurate way of identifying PTEN loss in biopsies and tissue sections so doctors can better match the type and amount of treatment to the aggressiveness of a tumor.

"The idea is that this test could be used in new cases of prostate cancer to help decide which of the many options is best suited for more aggressive cancers " says Jeremy Squire, who worked with a team of researchers in the Department of Pathology and Molecular Medicine. "The patient treatment from the get-go will be more appropriately planned."

PTEN is found in the nucleus of cancer cells and is considered one of the most important cancer-causing tumor-suppressor genes. If there is loss in the PTEN, it can inhibit the patient's ability to fight the cancer. It plays a critical role in a variety of cancers including prostate, breast, and lung cancers.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All